Webcast
The Journey Toward Paperless Clinical Trials
To view the media player you will need Adobe Flash!
Download Adobe Flash
Download Adobe Flash
The video player is loading...
Pharma companies are seeking to bolster pipelines and cut costs more than ever before in preparation for looming patent expirations of blockbuster drugs. In this environment global collaborations are increasing while budgets are shrinking, and as a result Internet-based communication has taken a prominent position in clinical development.
In contrast to the rapid changes in the structure of development teams and the advancements in web-based communications tools, the progress toward completely paperless clinical trials has been notably slow. Are we about to turn the corner and see new momentum? In over two decades since the first remote data entry systems were introduced, interfaces and speed of computer-based systems have improved greatly, yet the challenges of managing the paper distribution, collection and management of clinical regulatory documents in clinical trials persists.
Discussion includes:
In contrast to the rapid changes in the structure of development teams and the advancements in web-based communications tools, the progress toward completely paperless clinical trials has been notably slow. Are we about to turn the corner and see new momentum? In over two decades since the first remote data entry systems were introduced, interfaces and speed of computer-based systems have improved greatly, yet the challenges of managing the paper distribution, collection and management of clinical regulatory documents in clinical trials persists.
Discussion includes:
- The push for paperless continues: A look at the latest trends and initiatives
- Clinical studies end-to-end: Which parts of the process are farthest along and which have the highest hurdles
- Who benefits? Views on the benefits and burdens of transitioning to paperless for sites, sponsors, regulators and others
- Where from here? Practical next steps towards the paperless trial
More Webcasts
The Golden Rules of Restructuring Part 2: American View
Alix Partners, a global business advisory firm, provides their perspective which is complemented by top American restructuring practitioners who share their views on the impact restructuring is having on today's corporate landscape. This video is the second of the two part series produced by Debtwire and IntraLinks.
The Golden Rules of Restructuring Part 1: European View
London-based restructuring practitioners share their views on the current state of restructuring and bankruptcy and the golden rules of restructuring. The video is the first of a two part series produced by Debtwire and IntraLinks.
How to Reduce Costs and Shorten Study Start-up time
Clinical teams face greater challenges in sharing clinical trial information and safety documents with Sites, ECs, IRBs and CROs. In this webcast, discover ways to reduce the costs and minimize operational challenges associated with a paper-based study start-up process.
Renewable Energy ROI
In the energy industry opportunities for making money are competing for attention in the marketplace. In this webcast a panel of industry experts provides their unique views of the industry from both a development and a financing perspective.
2009 Deal Making in the Energy Sector
The search for alternate energy sources continues while financing and forecasting create murky waters for investors in both traditional and alternative energy production. Top industry experts openly discuss their views and vision for the future “on the record” and unscripted.
Did You Know?
IntraLinks also offers:
Success Story
immatics biotechnologies
Cancer drug developer immatics biotechnologies prides itself on open communication. Using IntraLinks to manage due diligence, immatics showed investors they could trust the company. What resulted was the largest private biotech financing round in Germany since 2001. In the process, immatics saved time and resources, and gave investors an efficient way to review information.